Can Blood Produced From Stem Cells Make Shortages a Thing of the Past?

Stem cell treatments are set to go mainstream as a UK consortium ramps up production of red blood cells from embryonic stem cells with plans to try it on human patients for the first time in 2016. Delivering blood transfusions through stem cells would push such therapies well into the medical mainstream. But it will also require industrial-scale production.